September 7, 2020

RESI

Sapere Bio selected by the NIH to participate and present at the RESI conference to advance commercial development of innovative technologies 

August 25-27, 2020

NextGen Advancing Diagnostics Virtual Global Summit

Connect with us at NextGen Dx, promising in-depth insights from diagnostics leaders, regulators and reimbursement experts

August 24, 2020

Accelerated aging and senescence linked in childhood cancer survivors

New data from Smitherman and colleagues at UNC, utilizing Sapere Bio technology, demonstrates the role of p16 in chemotherapy-accelerated aging, frailty and sarcopenia

July 26, 2020

Sapere Bio expands headquarters in RTP, NC

Doubled office space at "Frontier" headquarters in Research Triangle Park, a entrepreneurial biotech hub

February 25, 2020

Enrollment opens for GUARD-AKI Validation Trial 

Multi-site clinical trial of AKI-Sapere commences, supported by NIA Phase 2 SBIR funding 

February 24-27, 2020

25th Annual AKI and CRRT Conference

Updated data presented at leading international conference on acute kidney injury

March 1, 2019

15th Annual Biomarkers in Heart Failure and ACS Conference

We attended the 15th Annual Biomarkers in Heart Failure and ACS meeting in La Jolla, CA.

February 26-28, 2019

24th Annual AKI and CRRT Conference

Poster presentation of new data demonstrating AKI-Sapere can stratify patients by risk AKI before either CABG or cath/PCI.

February 13, 2019

WRAL TechWire Profiles Sapere Bio

January 1, 2019

HealthSpan Dx Renamed Sapere Bio

Sapere derives from the Latin meaning "to know." 

November 30, 2018

2018 Geriatric Oncology Symposium 

Natalia Mitin (HealthSpan Dx CEO), Hyman Muss, Andrew Smitherman, and Kirsten Nyrop (UNC clinicians) presented on p16 biomarker applications in oncology. More info

October, 2018

HealthSpan Dx Awarded Multi-Year SBIR Grant

HealthSpan Dx received a multi-year SBIR (Small Business Innovation Research) grant from the NIH and National Institute on Aging (NIA)

September 23-34, 2018

Precision Medicine World Conference 2018 Duke

Natalia Mitin, HealthSpan Dx CEO, presented "Bringing Biomarkers of Aging Into the Clinic."

October 1, 2018

HealthSpan Dx Moves to The Frontier

HealthSpan Dx tripled office and lab space with a move to custom-designed suits in the innovative Frontier campus.

May 17, 2018

RTP180 Presents: HealthSpan Diagnostics 

Natalia Mitin provided an overview of our work and history for RTP180, a seminar on entrepreneurship.